Core Insights - India accounts for approximately 50% of global snakebite fatalities, with around 50,000 deaths annually, and a total of up to 1.2 million deaths over the past 20 years [1] - The high mortality rate is attributed to inadequate government attention, poor infrastructure, and prevalent superstitions among the population [1] - The World Health Organization has prioritized snakebite envenoming as a neglected tropical disease to enhance governmental focus [1] Group 1 - Timely administration of antivenom is crucial for treating snakebites, as delays can lead to severe complications such as respiratory failure and irreversible organ failure [2] - India faces challenges with limited and non-specific antivenom availability, as current antivenoms only address bites from four major snake species, while the country has a diverse range of venomous snakes [2] - The National Action Plan for Prevention and Control of Snakebite Envenoming was launched in 2024, aiming to halve snakebite fatalities by 2030 through improved monitoring, increased antivenom supply, and public awareness campaigns [2]